These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25049046)

  • 41. Correspondence on 'Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial'.
    Satış H; Aydemir E; İzmirlioğlu K; Tufan A
    Ann Rheum Dis; 2022 Dec; 81(12):e256. PubMed ID: 32988847
    [No Abstract]   [Full Text] [Related]  

  • 42. [THE CERTAIN CLINICAL CHARACTERISTICS OF BLOOD IN PATIENTS WITH FAMILY MEDITERRANEAN FEVER OF ARMENIAN POPULATION].
    Pepoian AZ; Arutunian N; Grigorian A; Tsaturian VV; Manvelian AM; Dilnian E; Balaian MA; Torok T
    Klin Lab Diagn; 2015 Jun; 60(6):46-7. PubMed ID: 26466452
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Canakinumab reverses overexpression of inflammatory response genes in tumour necrosis factor receptor-associated periodic syndrome.
    Torene R; Nirmala N; Obici L; Cattalini M; Tormey V; Caorsi R; Starck-Schwertz S; Letzkus M; Hartmann N; Abrams K; Lachmann H; Gattorno M
    Ann Rheum Dis; 2017 Jan; 76(1):303-309. PubMed ID: 27474763
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation.
    Moser C; Pohl G; Haslinger I; Knapp S; Rowczenio D; Russel T; Lachmann HJ; Lang U; Kovarik J
    Nephrol Dial Transplant; 2009 Feb; 24(2):676-8. PubMed ID: 19033248
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Colchicine in familial Mediterranean fever.
    Lancet; 1977 May; 1(8022):1140-1. PubMed ID: 68234
    [No Abstract]   [Full Text] [Related]  

  • 46. Decreased vitamin D levels in children with familial Mediterranean fever.
    Anık A; Catlı G; Makay B; Abacı A; Küme T; Unsal E; Böber E
    Int J Rheum Dis; 2014 Mar; 17(3):321-6. PubMed ID: 24410734
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effective treatment of a colchicine-resistant familial Mediterranean fever patient with anakinra.
    Kuijk LM; Govers AM; Frenkel J; Hofhuis WJ
    Ann Rheum Dis; 2007 Nov; 66(11):1545-6. PubMed ID: 17934085
    [No Abstract]   [Full Text] [Related]  

  • 48. Effectiveness of Infliximab in colchicine resistant familial Mediterranean fever.
    Antón Vázquez V; Güell Farré E; Corominas H
    Med Clin (Barc); 2017 Dec; 149(11):510-511. PubMed ID: 28756998
    [No Abstract]   [Full Text] [Related]  

  • 49. Efficacy and safety of canakinumab in urticarial vasculitis: an open-label study.
    Krause K; Mahamed A; Weller K; Metz M; Zuberbier T; Maurer M
    J Allergy Clin Immunol; 2013 Sep; 132(3):751-754.e5. PubMed ID: 23711544
    [No Abstract]   [Full Text] [Related]  

  • 50. Neutrophil-derived S100A12 as novel biomarker of inflammation in familial Mediterranean fever.
    Kallinich T; Wittkowski H; Keitzer R; Roth J; Foell D
    Ann Rheum Dis; 2010 Apr; 69(4):677-82. PubMed ID: 19762364
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of familial Mediterranean fever with anakinra.
    Belkhir R; Moulonguet-Doleris L; Hachulla E; Prinseau J; Baglin A; Hanslik T
    Ann Intern Med; 2007 Jun; 146(11):825-6. PubMed ID: 17548423
    [No Abstract]   [Full Text] [Related]  

  • 52. Letter: Colchicine for familial Mediterranean fever (periodic peritonitis).
    N Engl J Med; 1974 Apr; 290(17):973. PubMed ID: 4816996
    [No Abstract]   [Full Text] [Related]  

  • 53. Colchicine failure in familial Mediterranean fever and potential alternatives: embarking on the anakinra trial.
    Ben-Zvi I; Livneh A
    Isr Med Assoc J; 2014 May; 16(5):271-3. PubMed ID: 24979828
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel therapeutics for the treatment of familial Mediterranean fever: from colchicine to biologics.
    Grattagliano I; Bonfrate L; Ruggiero V; Scaccianoce G; Palasciano G; Portincasa P
    Clin Pharmacol Ther; 2014 Jan; 95(1):89-97. PubMed ID: 23867542
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Familial Mediterranean fever. Continuous treatment with colchicine].
    Herlin T; Storm K; Ternowitz T
    Ugeskr Laeger; 1987 Jun; 149(24):1612-4. PubMed ID: 3603843
    [No Abstract]   [Full Text] [Related]  

  • 56. Transplacental passage of colchicine in familial Mediterranean fever.
    Amoura Z; Schermann JM; Wechsler B; Zerah X; Goodeau P
    J Rheumatol; 1994 Feb; 21(2):383. PubMed ID: 8182666
    [No Abstract]   [Full Text] [Related]  

  • 57. [Periodic fever suppressed by colchicine--a case report].
    Ota K; Sato T; Takahashi K
    Rinsho Shinkeigaku; 1986 Aug; 26(8):792-6. PubMed ID: 3802671
    [No Abstract]   [Full Text] [Related]  

  • 58. [Renal amyloidosis in a female with familial Mediterranean fever: clinical response to treatment with colchicine and infliximab].
    Heras M; Sánchez R; Saiz A; Fernández-Reyes MJ; Molina A; Alvarez-Ude F
    Nefrologia; 2009; 29(4):373-5. PubMed ID: 19668321
    [No Abstract]   [Full Text] [Related]  

  • 59. Effects of anti-tumor necrosis factor agents for familial mediterranean fever patients with chronic arthritis and/or sacroiliitis who were resistant to colchicine treatment.
    Bilgen SA; Kilic L; Akdogan A; Kiraz S; Kalyoncu U; Karadag O; Ertenli I; Dogan I; Calguneri M
    J Clin Rheumatol; 2011 Oct; 17(7):358-62. PubMed ID: 21946459
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Infantile colitis as a novel presentation of familial Mediterranean fever responding to colchicine therapy.
    Egritas O; Dalgic B
    J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):102-5. PubMed ID: 21694544
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.